Karyopharm Therapeutics News

Analysts Offer Insights on Healthcare Companies: Karyopharm Therapeutics (KPTI) and Siemens Healthineers AG (OtherSEMHF)

TipRanksMar 5 03:20 ET

Barclays Gives a Buy Rating to Karyopharm Therapeutics (KPTI)

TipRanksMar 4 02:55 ET

RBC Capital Remains a Buy on Karyopharm Therapeutics (KPTI)

TipRanksMar 1 07:28 ET

Karyopharm Therapeutics Analyst Ratings

BenzingaMar 1 07:09 ET

Analysts Offer Insights on Healthcare Companies: FibroGen (FGEN), Karyopharm Therapeutics (KPTI) and Day One Biopharmaceuticals (DAWN)

TipRanksFeb 26 22:30 ET

Piper Sandler Sticks to Their Buy Rating for Karyopharm Therapeutics (KPTI)

TipRanksJan 22 14:24 ET

Piper Sandler Reaffirms Their Buy Rating on Karyopharm Therapeutics (KPTI)

TipRanksJan 9 07:38 ET

RBC Capital Keeps Their Buy Rating on Karyopharm Therapeutics (KPTI)

TipRanksJan 5 20:47 ET

Hold Rating on Karyopharm Therapeutics: Evaluating Q3 Results, Impact of PAP and Prospects of Xpovio in Myelofibrosis Treatment

TipRanksNov 6, 2023 00:57 ET

RBC Capital Maintains Outperform on Karyopharm Therapeutics, Lowers Price Target to $3

BenzingaNov 3, 2023 14:56 ET

Karyopharm Therapeutics Analyst Ratings

BenzingaNov 3, 2023 14:54 ET

RBC Cuts Price Target on Karyopharm Therapeutics to $3 From $4, Keeps Outperform Rating

MT NewswiresNov 3, 2023 08:01 ET

Analysts' Top Healthcare Picks: Karyopharm Therapeutics (KPTI), Outlook Therapeutics (OTLK)

TipRanksNov 3, 2023 06:50 ET

Buy Rating Recommended for Karyopharm Therapeutics Amid Strong 3Q Results and Promising Xpovio Sales

TipRanksNov 3, 2023 06:21 ET

Karyopharm Therapeutics (KPTI) Gets a Buy From Piper Sandler

TipRanksOct 25, 2023 07:11 ET

RBC Capital Reaffirms Their Buy Rating on Karyopharm Therapeutics (KPTI)

TipRanksOct 5, 2023 21:49 ET

Analysts Are Bullish on These Healthcare Stocks: Karyopharm Therapeutics (KPTI), Pliant Therapeutics (PLRX)

TipRanksSep 29, 2023 02:31 ET

Karyopharm Therapeutics Analyst Ratings

BenzingaAug 7, 2023 11:38 ET

Robert W. Baird Sticks to Its Buy Rating for Karyopharm Therapeutics (KPTI)

TipRanksAug 4, 2023 03:36 ET

Karyopharm Therapeutics Analyst Ratings

BenzingaAug 3, 2023 12:52 ET